Primaxin and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Primaxin (cilastatin sodium; imipenem) and Decadron (dexamethasone). Common drug interactions include multi-organ failure among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Primaxin and Decadron. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Primaxin?

Primaxin has active ingredients of cilastatin sodium; imipenem. eHealthMe is studying from 4,540 Primaxin users. Check the latest studies of Primaxin.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 18, 2026

29 people who take Primaxin and Decadron together, and have interactions are studied.

Primaxin and Decadron drug interactions.

What are the common drug interactions of Primaxin and Decadron, by gender? *:

female:

  1. Multi-organ failure (multisystem organ failure)
  2. Organ failure
  3. Platelet count decreased
  4. Pleural effusion (water on the lungs)
  5. Pneumonia bacterial (pneumonia associated with bacterial infection)
  6. Vein disorder
  7. White blood cell count decreased
  8. White blood cell count increased
  9. Neutropenia (an abnormally low number of neutrophils)
  10. Caecitis (inflammation of the cecum)

male:

  1. Death
  2. Asthenia (weakness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Herpes zoster
  5. Oral herpes (viral infection of mouth)
  6. Pyrexia (fever)
  7. Weight decreased
  8. Blood bilirubin increased
  9. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  10. Hepatic function abnormal

What are the common drug interactions of Primaxin and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Caecitis (inflammation of the cecum)
  2. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  3. Hypersensitivity
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Pancreatitis (inflammation of pancreas)
  8. Platelet count increased
  9. Activated partial thromboplastin time prolonged
  10. Angiopathy (generic term for a disease of the blood vessels)

40-49:

  1. Body temperature increased
  2. Constipation
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Neutropenia (an abnormally low number of neutrophils)

50-59:

  1. Cytomegalovirus infection
  2. Epstein-barr virus infection
  3. Aortitis (inflammation of the aortic wall)

60+:

  1. Death
  2. Abdominal distension
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Haematuria present (presence of blood in urine due to trauma)
  5. Lethargy (tiredness)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Oedema lower limb (fluid collection in tissue of lower leg)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Breast Cancer: 4 people, 13.79%
  2. Nausea (feeling of having an urge to vomit): 3 people, 10.34%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Primaxin and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Primaxin and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Primaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Primaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cilastatin sodium; imipenem and dexamethasone (the active ingredients of Primaxin and Decadron, respectively), and Primaxin and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: